Gschäftsbericht 2018

Galenica financial statements 2018 | 109 Finance Notes to the consolidated financial statements of the Galenica Group Cash flow from financial liabilities 2017 in thousand CHF 1 January Cash flow from financing activities Addition to scope of consolidation Changes in financing structure related to separation Other changes 31 December Financial receivables from cash pooling arrangement with Vifor Pharma Group (340,500) 3,865 — 336,635 — — Bank loans — (7,000) 7,000 — — — Loans 472 66 450 3,112 35 4,135 Loans to Vifor Pharma Group 1,110,204 (360,000) — (750,204) — — Liabilities to pension funds — 9,987 — 8,608 — 18,595 Bonds — 380,806 — — (59) 380,747 Other financial liabilities 4,504 — — — (1,691) 2,813 Total 774,680 27,724 7,450 (401,849) (1,715) 406,290 19. Trade and other payables in thousand CHF 2018 2017 Trade payables 268,972 262,985 Contract liabilities 8,058 8,172 Other payables 21,137 22,103 Trade and other payables 298,167 293,260 Contract liabilities are generally recognised in revenue within 12 months. 20. Provisions Accounting principles Provisions are recorded when Galenica has a present legal or constructive obligation towards a third party as a result of a past event, when the amount of the obligation can be reliably estimated and an outflow of economic resources is probable. Provisions are recognised for the estimated cost of liabilities related to sureties, customer complaints, litigation risks and ongoing legal proceedings. in thousand CHF 2018 2017 1 January 7,615 3,587 Addition 1,173 5,274 Use (1,699) (3,153) Reversal (716) (1,602) Addition to scope of consolidation — 3,509 31 December 6,373 7,615 – of which current provisions 2,657 2,172 – of which non-current provisions 3,716 5,443 In 2017, the addition primarily consisted of a provision of CHF 5.0 million recorded for a guarantee for future lease pay- ments related to the sale of a building. The cash outflow from the non-current provisions is expected within the next 1 to 5 years.